/
ASTH
$45.03+$0.52 (+1.17%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$2.2B
50M shares
52-week range
$18.08 – $45.08
100% from low
Sector
SERVICES-MANAGEMENT CONSULTING SERVICES
Exchange
NASDAQ
CS
Borrow rate
0.27%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$2.24
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $519.9M | $560.6M | $370.2M | $773.9M | $1.14B | $1.39B | $2.03B | $3.18B |
| Cost of revenue | $380.4M | $467.8M | $348.5M | $596.1M | $944.7M | $1.17B | $1.76B | $2.89B |
| Gross profit | $139.5M | $92.8M | $21.7M | $177.8M | $199.5M | $215.0M | $271.4M | $295.8M |
| Gross margin | 26.8% | 16.6% | 5.9% | 23.0% | 17.4% | 15.5% | 13.3% | 9.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $92.2M | $32.4M | $6.1M | $98.2M | $104.3M | $84.6M | $89.3M | $78.5M |
| EBITDA | $102.5M | $48.9M | $29.7M | $100.7M | $112.1M | $123.7M | $141.8M | $135.3M |
| Net income | $10.8M | $14.1M | −$23.8M | $68.9M | $45.2M | $60.7M | $43.1M | $22.5M |
| Net margin | 2.1% | 2.5% | -6.4% | 8.9% | 3.9% | 4.4% | 2.1% | 0.7% |
| EPS (diluted) | 0.29 | 0.39 | 1.01 | 1.52 | 0.99 | 1.29 | 0.90 | 0.46 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $4.0B | $1.27 | $1.20–$1.33 | 4 |
| 2027 | $4.4B | $1.87 | $1.62–$2.12 | 4 |
| 2028 | $4.7B | $2.74 | $2.53–$2.95 | 2 |
| 2029 | $5.1B | $3.08 | $3.00–$3.18 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$61.72
Price
$45.03
Implied upside
+37%
Peer comparison
Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
www.astranahealth.com- Employees
- 3,000
- IPO / List date
- Nov 26, 2007
- HQ
- ALHAMBRA, CA
Held by traders on TradeandTell
No one on the platform currently holds ASTH.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 104,546 | $2.6M |
| Bridgewater Associatesas of 2024-09-30 | 16,424 | $951.6K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ASTH yet.
